elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-8E65D02A-B683-4C18-AF5F-F3FCD635CE27
Q27852097-8E65D02A-B683-4C18-AF5F-F3FCD635CE27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-8E65D02A-B683-4C18-AF5F-F3FCD635CE27
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P2093
Q27852097-8E65D02A-B683-4C18-AF5F-F3FCD635CE27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-8E65D02A-B683-4C18-AF5F-F3FCD635CE27
rank
NormalRank
type
BestRank
Statement
P1545
15
http://www.w3.org/2001/XMLSchema#string
P2093
Zancong Shen
http://www.w3.org/2001/XMLSchema#string